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Bruno da Silva B. Gonçalves1, Francieli S. Ruiz2,3, Felipe Beijamini3,4, Fabiana
S. Evangelista1, Homero Vallada3, Jose Eduardo Krieger4, Malcolm von Schantz2,
Alexandre C. Pereira5, Mario PedrazzoliID
1
1 School of Arts, Science and Humanities, University of São Paulo, São Paulo, Brazil, 2 Faculty of Health
and Medical Sciences, University of Surrey, Guildford, Surrey, United Kingdom, 3 Institute of Psychiatry,
University of São Paulo Medical School, São Paulo, Brazil, 4 Federal University of Fronteira Sul (UFFS),
Realeza, Brazil, 5 Laboratory of Genetics and Molecular Cardiology, Heart Institute (InCor), University of São




Metabolic syndrome (MetS) is a complex condition comprising a ‘clustering’ of components
representing cardiometabolic risk factors for heart disease and diabetes; its prevalence rate
is high and consequences serious. Evidence suggests that light exposure patterns and mis-
alignment of circadian rhythms might contribute to MetS etiology by impacting energy
metabolism and glucose regulation.
Objective
We hypothesised that individuals with MetS would show disrupted circadian and sleep
parameters alongside differences in light exposure profiles. We investigated this using data
from a cohort study in Brazil.
Methods
Data from 103 individuals from the Baependi Heart Cohort Study aged between 50 and 70
were analysed. Motor activity and light exposure were measured using wrist-worn actigra-
phy devices. Cardiometabolic data were used to calculate the number of MetS components
present in each participant, and participants grouped as MetS/non-MetS according to stan-
dard guidelines. Between-group comparisons were made for the actigraphy measures;
additionally, correlation analyses were conducted.
Results
Motor activity and circadian profiles showed no differences between groups. However, the
MetS group presented lower light exposure during the day and higher light exposure at
night. Correlation analyses, including all participants, showed that greater daytime light
exposure and greater light exposure difference between day and night were associated with
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reduced MetS risk (a lower number of MetS components). Also, the light exposure differ-
ence between day and night correlated with body mass index across all participants.
Conclusions
The observed results suggest a direct association between light exposure and MetS which
appears to not be attributable to disruptions in circadian activity rhythm nor to sleep parame-
ters. This link between light exposure patterns and MetS risk could inform possible preven-
tion strategies.
Introduction
Metabolic syndrome (MetS) is a complex condition defined by a clustering of cardiometabolic
components including hyperinsulinemia, glucose intolerance, dyslipidemia, obesity, and high
blood pressure. Meeting criteria on at least three of these is required for a MetS diagnosis. The
prevalence of MetS is increasing globally; it is estimated that 20 to 25% of the total adult popu-
lation meet criteria for MetS [1–3]. The consequences are severe: there is a 1.5- to 2.5-fold
increase in risk of cardiovascular events and mortality in those with MetS [3]. Consequently,
MetS places substantial burden on societies and health care systems worldwide [4–7].
Insulin resistance associated with central obesity is typically regarded as the primary cause
of MetS [8], driven by an imbalance between total calorie intake and total energy expenditure.
Genetic factors clearly contribute to obesity risk [9]; however, the pathogenesis of MetS
includes other factors such as lifestyle and metabolic consequences of obesity [8]. Physical
inactivity is thought to have a role [10], and sleep quality [11] and duration [12] have also been
implicated. Recent work has focused on the potential role of circadian misalignment in meta-
bolic syndrome. Misalignment of sleep to the biological night has been shown to have a range
of adverse consequences, raising risk for cardiovascular disease, diabetes, obesity, and other
disorders [13]. Circadian organisation of endocrine function regulates energy homeostasis,
imposing a temporal structure on various metabolic processes. Since abnormal circadian
rhythms have been associated with nearly all the individual components of MetS, this has
prompted some authors to suggest that circadian rhythm disturbances could be central to
MetS aetiology, even proposing that MetS be renamed the ‘Circadian Syndrome’ [14]. Likely
underlying mechanisms include mismatched timing of food intake, changes in gut micro-
biome, and dysregulation of metabolic hormones [15]. Amongst these, melatonin (a neurohor-
mone with a diverse array of functions) plays a prominent role.
The circadian rhythm of melatonin secretion can have effects on sleep-wake cycle, as well
as on the entrainment of peripheral circadian clocks [15], and has direct effects on energy
metabolism via peripheral targets. Melatonin improves glucose homeostasis by protecting the
pancreas against glucotoxicity [16] and exerts effects on body weight, insulin sensitivity and
glucose tolerance [17,18]. Melatonin is secreted mainly during the biological night [19] and its
synthesis is blocked by light via the retinal hypothalamic tract [20,21]. Contemporary lifestyles,
particularly in urban communities, increase exposure to artificial light at night [22–24] which
affects melatonin secretion profiles [25,26] with consequent effects on energy metabolism; the
short-wavelength light produced by LED screens is particularly disruptive [15]. This could
explain why large epidemiological studies have shown a direct relationship between obesity
and light exposure at night, even when adjusting for other factors such as sleep duration and
physical activity [27]. Studies comparing satellite images of night time illumination with
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obesity rates have shown that light at night correlates with obesity rate both between [28] and
within [29] countries. This parallels rodent work showing that even low levels of night time
light alter the timing of food intake and leads to excess weight gain [30].
It is therefore unsurprising that artificial light at night also raises MetS risk. This has been
demonstrated in studies of shift workers: those who work and are exposed to high levels of
light at night have a higher prevalence of MetS compared to those who only work during the
day [31,32]. Simulated night shift conditions in the laboratory cause leptin reduction, insulin
resistance, reversal of the rate of cortisol release and increases in blood pressure after just 10
days [33]. However, while various studies have investigated the link between MetS and shift
work patterns (either in shift workers or under simulated conditions) [34], much less work has
been done in community-based samples. A study in Finland found that seasonal variations in
weight and appetite, as well as artificial lighting at home, strongly contributed to MetS risk
[35]. Thus, light exposure patterns might be a critical (and correctable) factor in the etiology of
MetS. A breakdown in circadian rhythm stability could play a causal role since irregular
24-hour activity rhythms raises risk of MetS [36]. Effects on sleep duration might also contrib-
ute since short sleep duration also raises risk of MetS [37].
To explore these possibilities, we analysed data from the Baependi Heart Study, which
began in 2005 as a longitudinal cohort study to evaluate environmental and genetic effects on
cardiovascular disease risk factors [38]. Baependi is a small rural town in the state of Minas
Gerais, Brazil, with a traditional lifestyle and moderate and ongoing urbanization. Previous
work in this cohort has shown that individuals in the rural zone show a shift of diurnal prefer-
ence towards morningness [39], compared to those in the urban zone (who themselves are
strongly shifted towards morningness compared to metropolitan areas). Here, we have focused
on the link between MetS and patterns of light exposure in this community-dwelling sample,
utilizing actigraphy and cardiometabolic data. We assessed the number of components each
participant met for MetS criteria and categorized participants into either MetS or non-MetS
groups accordingly. Measures of circadian rhythm stability and sleep duration were derived
from motor activity collected using wrist-worn actigraphy devices. Levels of diurnal and noc-
turnal light exposure were also collected using the same devices. We then compared circadian
rhythm and light exposure profiles between groups. Based on previous findings, we hypothe-
sised that the MetS group would show a disruption in circadian rhythms stability and greater
night-time light exposure. Follow-up correlation analyses across all participants investigated
possible association between these parameters and the number of MetS components present in
everyone. Finally, we investigated possible correlations between these parameters and mea-
sures of glycated haemoglobin A1c (HbA1c) and body mass index (BMI), since the evidence
outlined above suggests that circadian disruption and light exposure patterns might specifically
affect glucose regulation and obesity levels.
Methods
Participants
Participants were drawn from the Baependi Heart Cohort Study [38]. In short, the full study
sample consists of 2,239 participants aged between 18 and 91 (42.5±17.2 years old). A subsam-
ple of 103 participants aged between 50 and 70 years old was invited to provide actigraphy
data, since metabolic syndrome is highly age dependent [40]. These participants were distrib-
uted across 42 extended pedigrees, which from now on are referred to as “families” [41].
Included in the study were 22 families with only one participant, and 20 with more than one
participant. Inclusion criteria were at least five days of complete actigraphy data and all requi-
site cardiometabolic parameters available.
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Ethics statement
All participants gave written informed consent before participation. This study protocol con-
formed to international ethics standards based on the Declaration of Helsinki and was
approved by the local ethics committee (Hospital das Clı́nicas–Universidade de São Paulo,
Brazil) (approval number 0494/10).
Clinical parameters
The I Brazilian Guideline on Diagnosis and Treatment of Metabolic Syndrome (I-DBSM) [42]
was used to categorise the non-metabolic syndrome group (non-MetS; individuals meeting
criteria on less than 3 components) and the metabolic syndrome group (MetS; individuals
meeting criteria on 3 or more components). The I-DBSM is based on the National Cholesterol
Education Program’s Adult Treatment Panel III (NCEP-ATP III) guidelines which defines
MetS criteria and components as follows: Abdominal obesity (abdominal circumference: men
>102 cm, women >88 cm), increased triglycerides (�150 mg/dL for men or women, or use of
lipid-lowering medication), reduced HDL cholesterol (men <40 mg/dL, women <50 mg/dL),
increased blood pressure (systolic�130 mmHg or diastolic�85 mmHg for men or women, or
use of antihypertensive medication), and increased fasting glycemia (�110 mg/dL for men or
women, or presence of type 2 diabetes or diabetic treatment).
Smoking status (current, former, never) and level of education (in years) were recorded.
Height and waist circumference were measured in centimetres and weight in kilograms using
a calibrated digital balance. Body mass index (BMI) was calculated as body weight (kg) divided
by height squared (m2). Systolic (SBP) and diastolic blood pressure (DBP) were calculated by
taking the mean of three readings (minimum interval of 3 min between readings) using a stan-
dard digital sphygmomanometer (OMRON, Kyoto, Japan) on the left arm after 5 min rest, in
the sitting position. High- and low-density lipoproteins, triglycerides, total cholesterol and
fasting glucose were evaluated by standard techniques in 12-h fasting blood samples. HbA1c
levels were determined by high-performance liquid chromatography (HPLC).
Actigraphy
Participants were instructed to wear the actigraphy device that contained an accelerometer
and light and temperature sensors (ActTrust AT0503, Condor Instruments, São Paulo, SP,
Brazil). We analysed five consecutive days of use on their non-dominant wrist. Actigraphy
measures were first calculated for each day, and then averaged. Most of the data were mea-
sured over the work week, but in a few cases, weekend data had to be included due to an excess
of off-wrist occurrences. The devices recorded activity using 60-second epochs. The actigraphy
software, ActStudio, provided an estimation of the sleep duration, bedtime and wake-up time
based on the Kole-Kripke modified algorithm (Condor Instruments, São Paulo, Brazil).
Table 1 shows motor activity and light exposure variables derived from actigraphy.
Statistical analyses
All statistical analyses were performed using the Statistical Package for the Social Sciences, ver-
sion 21.0 (SPSS, Chicago, IL). Normal distribution was confirmed by the Kolmogorov–Smir-
nov test for all variables of interest. Data were log10 transformed prior to statistical analyses in
the case of non-normal distribution (L5, IS, IV, L8_light, and RA_light, bedtime, and wake-up
time). Between-group comparisons on participant characteristics were conducted using Stu-
dent’s t-tests (for continuous variables) and Pearson’s χ2 test (for categorical variables).
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A linear mixed model was used for comparisons of motor activity, light exposure, and sleep
parameters, considering the family cluster as a random factor and the residential zone (urban
and rural), MetS risk (MetS and non-MetS), age and sex as fixed factors.
Follow-up analyses explored Pearson’s correlations between specific actigraphy parameters
with a number of MetS components, with BMI and with HbA1c. The entire sample (MetS and
non-MetS groups) was used for these analyses to explore possible associations in the general
population. In order to avoid type I-error, Bonferroni-corrected multiple comparisons thresh-
olds were employed. The significance level adopted in all analyses was p<0.05.
Results
Participant characteristics
Participant characteristics are shown in Table 2. The sample (total N = 103) was subdivided
into 2 groups according to MetS diagnosis. The non-MetS group (50.5%) comprised 52 indi-
viduals and the MetS group (49.5%) comprised 51 individuals. These groups did not differ
with respect to age, education, smoking status, and residential zone. The BMI was higher in
the MetS group as compared to the non-MetS group (29.6±4.8 kg/m2 vs 24.9±4.1 kg/m2,
p<0.001).
Light exposure, motor activity, and sleep parameters separated by groups
The linear mixed model analysis revealed a MetS risk group effect on light exposure parame-
ters. The MetS group showed a decrease in diurnal light exposure (M16_light, p = 0.007) and
increased in nocturnal light exposure (L8_light, p = 0.021) compared to the non-MetS group.
Accordingly, the normalised difference between diurnal and nocturnal light exposure
(RA_light, p = 0.016) was significantly lower in the MetS group, see Table 3. Averaged light-
exposure profiles for each group are shown in Fig 1.
Table 1. Motor activity and light expositions variables obtained from actigraphy.
M10: mean diurnal motor activity
(counts/min)
daily average of the 10 most active consecutive hours over 5 days [43–45]
L5: mean nocturnal motor activity
(counts/min)
daily average of the 5 less active consecutive hours over 5 days [43–45]
RA: motor activity (day minus night,
normalised)
RA = (M10-L5)/(M10+L5). RA values range from 0 to 1, and higher values
indicate higher activity during the day relative tonight [45]
P10: phase of M10 onset (hh:min) corresponds to the onset of the M10 phase, i.e., the onset of the 10 most
active consecutive hours of motor activity
P5: phase of L5 onset (hh:min) corresponds to the onset of L5 phase, i.e., the onset of the 5 less active
consecutive hours of motor activity
IS: interdaily stability corresponds to the circadian rhythm stability of motor activity over 5 days;
a high IS value indicates a more synchronized rest/activity rhythm [46]
IV: intradaily variability corresponds to the circadian rhythm fragmentation of motor activity; a
high IV value indicates a more fragmented rest/activity rhythm (for
example, occurrence of daytime naps and/or episodes of night time
activity) [46]
M16_light: mean diurnal light
exposure (lux)
daily average of the 16 consecutive hours with more exposure to light over
5 days
L8_light: mean nocturnal light
exposure (lux)
daily average of the 8 consecutive hours with less light exposure over 5 days
RA_light: light exposure (day minus
night, normalised)
RA_light = (M16_light—L8_light)/(M16_light + L8_light)). RA_light
values range from 0 to 1, and higher values indicate higher light exposure
during the day relative to light exposure at night [45]
https://doi.org/10.1371/journal.pone.0238772.t001
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There were no statistical differences between groups in the circadian parameters, interdaily
stability (IS) and intradaily variability (IV). No statistical differences were observed between
groups for motor activity parameters. Moreover, the averaged onset of diurnal activity (P10)
occurred between 7:57 and 8:31, and the averaged onset of nocturnal activity (P5), between
24:31 and 24:58 in Non-MetS and MetS group, respectively. Averaged motor activity profiles
for each group are shown in Fig 2.
Non-MetS and MetS groups did not differ in sleep parameters: bedtimes (around 23:00),
wake-up times (around 06:00) and sleep durations (around 7 hours) (Table 3).
Correlation analyses
To further explore these findings, we tested across the entire sample of participants for correla-
tions between the number of MetS components each participant met criteria for, and the diur-
nal motor activity (M10), interdaily stability (IS), diurnal light exposure (M16_light),
nocturnal light exposure (L8_light) and the normalised difference between diurnal and noc-
turnal light exposure (RA_light) parameters. Since five correlations were computed, a Bonfer-
roni-corrected multiple comparisons threshold of 0.05/5 = 0.01 was employed. There was no
correlation between number of MetS components and diurnal motor activity (M10) (r = -0.40,
p = 0.692), interdaily stability (IS) (r = 0.205, p = 0.037) or nocturnal light exposure (L8_light)
(r = 0.198, p = 0.045). However, there were significant negative correlations between number
of MetS components and diurnal light exposure (M16_light) (r = -0.333, p = 0.001), and
Table 2. Participant characteristics, for total and separated by MetS groups.
Total Non-Metabolic Syndrome Metabolic Syndrome p-value
N (%) 103 (100) 52 (50.5) 51 (49.5)
Male:Female 39:64 24:28 15:36 0.080�
Age, y.o. 58.1 (5.7) 58.2 (6.0) 58.0 (5.4) 0.892+
Education, years 6.6 (3.8) 6.7 (5.2) 6.5 (4.3) 0.899+
Smoking status 0.213�
Former smokers, N (%) 36 (34.9) 17 (32.7) 19 (37.2)
Current smokers, N (%) 15 (14.5) 5 (9.6) 10 (19.6)
Never smokers, N (%) 49 (47.6) 30 (57.7) 19 (37.2)
Residential zone 0.974�
Rural, N (%) 10 (9.7) 5 (9.6) 5 (9.8)
Urban, N (%) 93 (90.3) 47 (90.4) 46 (90.2)
BMI, kg/m2 27.2 (5.0) 24.9 (4.1) 29.6 (4.8) <0.001+
High blood pressure, N (%) 38 (36.9) 14 (26.9) 24 (47.1) 0.034�
High waist circumference, N (%) 53 (51.5) 13 (25.0) 40 (78.4) <0.0001�
Low HDL cholesterol, N (%) 60 (58.3) 17 (32.7) 43 (84.3) <0.0001�
High triglycerides, N (%) 43 (41.7) 8 (15.4) 35 (68.6) <0.0001�
High fasting glucose, N (%) 12 (11.7) 0 (0.0) 12 (23.5) <0.0001�
Drug treatment for hypertension, N (%) 42 (40.1) 11 (21.2) 31 (60.8) <0.0001�
Drug treatment for dyslipidemia, N (%) 18 (17.5) 7 (38.9) 11 (61.1) <0.0001�
Drug treatment for Type 2 diabetes, N (%) 11 (10.7) 1 (1.9) 10 (19.6) <0.0001�
Data are expressed as means (SD) or percentages (total N = 103) or (N = 52 or N = 51, for non-MetS or MetS groups, respectively). Significant p-values (p) are
represented in bold and italic.
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between number of MetS components and normalised difference between diurnal and noctur-
nal light exposure (RA_light) (r = -0.264, p = 0.007). Greater daytime light exposure, and a
larger normalised difference between diurnal and nocturnal light exposure (RA_light) were
significantly correlated with a reduced MetS risk.
Further correlations were computed to explore effects on specific cardiometabolic parame-
ters. Based on prior evidence we focused on glycaemic control and obesity measures (HbA1c
and BMI). Correlations between these and diurnal motor activity (M10), diurnal light expo-
sure (M16_light), nocturnal light exposure (L8_light) with the normalised difference between
diurnal and nocturnal light exposure (RA_light) were assessed. A total of 8 correlations were
computed requiring a Bonferroni-corrected threshold of 0.05/8 = 0.00625. The only significant
correlation found was between BMI and the normalised difference between diurnal and noc-
turnal light exposure (RA_light) (r = -0.301, p = 0.002), see Fig 3. Evidence of other relation-
ships were found but did not meet the Bonferroni-corrected threshold for significance:
between diurnal light exposure (M16_light) and HbA1c (r = -0.210, p = 0.033), diurnal light
exposure (M16_light) and BMI (r = -0.228, p = 0.023), and between diurnal motor activity
(M10) and HbA1c (r = -0.235, p = 0.017).
Discussion
This study aimed to investigate alterations in circadian rhythms in individuals with metabolic
syndrome in a sample from a small rural town in Brazil. We found that individuals with a
MetS diagnosis recorded considerably less light exposure during the day and more light expo-
sure at night. Motor activity and sleep parameters did not differ between groups. This points
to a specific association between light exposure profiles and MetS risk, and this was
Table 3. Motor activity, light exposure and sleep variables, separated by groups.
Dependent variables Non-Metabolic Syndrome Metabolic Syndrome p-value (multilevel modelling
analyses)
mean (SD) -95% CI +95% CI mean (SD) -95% CI +95% CI
Diurnal motor activity, M10 (counts�106/min) 39.2 (13.8) 23.0 52.5 39.3 (11.8) 25.1 54.4 0.250
Nocturnal motor activity, L5 (counts�103/min) 42.5 (20.2) 33.0 50.1 45.3 (22.8) 37.4 54.3 0.472
Motor activity (day minus night, normalised), RA 0.98 (0.11) 0.95 0.99 0.98 (0.12) 0.95 0.99 0.578
Diurnal motor activity onset time (min), P10 7:58 (1:30) 4:04 12:55 8:34 (2:03) 4:08 12:54 0.905





Interdaily Stability, (IS) 0.59 (0.10) 0.45 0.69 0.63 (0.09) 0.49 0.73 0.090
Intradaily Variability (IV) 0.63 (0.15) -2.3 3.5 0.62 (0.14) -2.3 3.5 0.540
Diurnal light exposure, M16_light (lux) 3372 (784) -374 6916 2931 (680) -343 6341 0.007
Nocturnal light exposure, L8_light (lux) 250 (151) 102 345 305 (114) 161 404 0.021
Light exposure (day minus night,normalised), RA_
light
0.84 (0.10) 0.26 1.46 0.79 (0.09) 0.21 1.41 0.016
Sleep duration (hours:minutes) 07:09
(0:55)






Wake-up time (hours:minutes) 06:39
(1:35)
05:15 08:07 6:13 (3:58) 04:50 07:55 0.556
Multilevel modelling analysis, considering the family cluster as a random factor and metabolic syndrome status, age, address, and sex as fixed factors. Significant p-
values (p) are represented in bold and italic.
SD: Standard deviation; -95% CI and +95% CI: 95% confidence interval limits.
https://doi.org/10.1371/journal.pone.0238772.t003
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demonstrated by correlation analyses. These considered all individuals in the sample and
showed that MetS risk (the number of MetS components individuals’ met criteria for) corre-
lated with light exposure patterns. Specifically, greater diurnal light exposure and a greater
normalised difference between diurnal and nocturnal light exposure (RA_light) was correlated
with reduced MetS risk. RA_light was also seen to negatively correlate with BMI.
These findings accord with previous results showing links between light exposure and
MetS. Shift workers exposed to high levels of light at night have a higher prevalence of MetS
[31,32]. Studies using satellite imagery have linked light at night with obesity levels [28,29]. A
recent study analysed self-report data of bedroom light levels and found associations with risk
of weight gain in women aged 35 to 74 [47]. This is important since obesity and associated
insulin resistance is critical in the etiology of MetS [8]. The current study adds further insight
into these relationships. Unlike most previous work, data were collected in a naturalistic com-
munity-dwelling sample and parameters were measured objectively using actigraphy. Previous
studies have focused on light at night and we found that a MetS diagnosis was associated with
greater nighttime light exposure. However daytime light exposure and the normalised differ-
ence between diurnal and nocturnal light exposure (RA_light) were significantly different
between MetS and non-MetS groups. Correlational analyses underlined the importance of
these parameters as they correlated negatively with BMI across the whole sample. Although
few previous studies have addressed this question, work by Reid et al. [48] showed that more
light exposure earlier in the day correlated with lower BMI in a young to mid-age sample. Reid
et al. found no effects of nighttime light, although their sample of N = 54 had low levels of
nighttime light exposure overall. The current study capitalises on the high levels of variance
Fig 1. 24-hour profiles of light exposure, separated by groups. Data are represented in a double plot averaged across
five days. The means (bold line) and standard error of the means (shadow) are presented for the MetS group (blue) and
Non-MetS group (red).
https://doi.org/10.1371/journal.pone.0238772.g001
PLOS ONE Association between light exposure and metabolic syndrome
PLOS ONE | https://doi.org/10.1371/journal.pone.0238772 September 18, 2020 8 / 16
within the Baependi population to show that individuals in this cohort with higher daytime
and lower nighttime light exposure have lower BMI and less chance of a MetS diagnosis.
There are various possible mechanisms which might underlie these effects. The circadian
temporal system modulates physiological homeostasis via effects on endocrine and neuroen-
docrine systems [see 49,50], circadian misalignment has been considered as a possible link
between light exposure and metabolic disorders. Shift work has been used to study the effects
of circadian misalignment, evidencing higher incidence of diabetes, obesity, and cardiovascu-
lar events [51,52] and laboratory studies of simulated shift work support these findings [33].
Since sunlight is the primary temporal cue for humans, one possibility is that greater daytime
light exposure (and lower nighttime light exposure) promotes better circadian alignment with
a concomitant reduction in MetS risk. However, this circadian mechanism cannot explain our
results, since circadian parameters did not differ between groups. This was contrary to expec-
tations given previous findings linking irregular activity rhythms to MetS and its components
[36]. Likewise, sleep timing did not differ between groups: previous results have linked short
sleep duration to MetS risk [37] although long (>10 hours) sleep duration has also been impli-
cated [12] which might have affected our ability to detect differences. Also, given the cross-sec-
tional nature of the current study we cannot rule out the possibility that circadian instability
and short sleep earlier in life might have contributed to the development of MetS in the indi-
viduals studied here. Nevertheless, the data suggest that other mechanisms directly related to
light exposure might be at play.
One possibility is a light-induced modulation of metabolic processes. In humans, studies
that manipulate light exposure patterns have shown that a diminished light–dark cycle under-
mines the diurnal rhythm of metabolism: diet-induced thermogenesis following a meal is
Fig 2. 24-hour profiles of motor activity profiles, separated by groups. Data are represented in a double plot
averaged across five days. The means (bold line) and standard error of the means (shadow) are presented for the MetS
group (blue) and Non-MetS group (red).
https://doi.org/10.1371/journal.pone.0238772.g002
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influenced by light exposure patterns across the day and night [53]. Melatonin is implicated in
this. Even low levels of light at night can disrupt melatonin secretion with adverse effects on
health [54,55] and melatonin has direct effects on energy metabolism via peripheral targets.
Melatonin has an important role in regulating lipid and glucose metabolism [56]; for example,
melatonin influences insulin secretion via pancreatic melatonin receptors [57]. Intervention
studies provide supporting evidence. One year of melatonin treatment reduced fat mass in
postmenopausal women [58] while positive effects on BMI have been shown after just 12
weeks of melatonin treatment in young obese adults [59]. The anti-inflammatory and antioxi-
dant effects of melatonin might also contribute [60]. We found that nighttime light exposure
was greater in the MetS group, while a smaller normalized difference between day and night
light exposure levels was associated with higher BMI and raised MetS risk across the whole
sample. Follow up work should explore whether effects on melatonin levels might underlie
these relationships.
Fig 3. Scatterplot of BMI (body mass index) and normalised difference between diurnal and nocturnal light exposure. Data are presented with
points for the MetS group (blue) and Non-MetS group (red). Across the entire sample, a line has been drawn to facilitate the calculated correlation
display.
https://doi.org/10.1371/journal.pone.0238772.g003
PLOS ONE Association between light exposure and metabolic syndrome
PLOS ONE | https://doi.org/10.1371/journal.pone.0238772 September 18, 2020 10 / 16
Effects on vitamin D synthesis is another possible mechanism underlying the findings
reported here. Most of our vitamin D stores derive from the absorption of sunlight by the skin,
and evidence points to vitamin D deficiency as a risk factor for obesity, hypertension, diabetes
and, consequently, metabolic syndrome and cardiovascular disease [61–66]. Schmitt et al. [67]
linked vitamin D deficiency to metabolic syndrome in postmenopausal women, a sample com-
parable to that studied here. Women with vitamin D deficiency had a higher risk of developing
MetS, hypertriglyceridemia and low HDL levels [67]; other studies have shown negative effects
on total cholesterol, triglycerides and insulin [65,68,69]. Nevertheless, since results from vita-
min D supplementation trials have been inconclusive [70], the beneficial effects of sunlight
exposure might go beyond that of enhancing vitamin D stores. Sunlight exposure has positive
effects on the immune system, reducing chronic systemic inflammation and upregulating anti-
inflammatory immune processes [71]. Also, heat from the sun can itself modulate glucose
metabolism since heat increases vasodilation in peripheral tissues and promotes uptake of glu-
cose and insulin [72]. Here, we found that across the whole sample, daytime light exposure
(M16_light) correlated negatively with HbA1c levels and BMI (although these did not survive
multiple comparisons correction) which is in line with these previous findings. Adequate sun
exposure appears to be important for cardiometabolic health.
There are therefore multiple routes by which light exposure patterns could impact MetS risk
parameters. While much previous work has focused on the effects of circadian misalignment and
light at night, the current findings suggest that daytime light exposure and the normalized differ-
ence between day and night light exposure levels also strongly contribute. These might be due to
effects on melatonin and/or vitamin D synthesis; sunlight exposure itself has other direct effects
that could be relevant, and future studies should investigate these possibilities. Limitations of the
current work include the cross-sectional design, mostly female study sample (which precludes
study of sex effects) and the lack of food intake data, which could help determine how light expo-
sure impacts caloric intake and/or timing. Strengths include the use of objective actigraphic and
cardiometabolic data and the use of a sample in which MetS and non-MetS groups were well
matched on demographic and physical activity (diurnal motor activity (M10)) parameters.
In conclusion, these findings provide novel insight into associations between light exposure
patterns and MetS risk. A MetS diagnosis was linked to less light exposure during the day and
more light exposure at night without any difference in circadian parameters. Across the whole
sample, more light exposure during the day and a greater normalised difference between day
and night light exposure levels correlated with reduced MetS risk. Although the data do not
allow causal inferences to be made, these findings do raise the possibility that relatively
straightforward lifestyle modifications (ensuring adequate daytime sun exposure and reducing
bedroom light levels) could be effective in reducing the prevalence of MetS. Since the current
results were observed in a semi-rural environment where individuals tend to have relatively
high/low levels of day/night light exposure, such effects might be even more pronounced in
urban environments and merit further investigation.
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Writing – review & editing: Ana Amélia Benedito-Silva, Simon Evans, Juliana Viana Mendes,
Juliana Castro, Francieli S. Ruiz, Felipe Beijamini, Malcolm von Schantz, Mario Pedrazzoli.
References
1. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the Met-
abolic Syndrome. Circulation. 2009; 120: 1640–1645. https://doi.org/10.1161/CIRCULATIONAHA.109.
192644 PMID: 19805654
2. Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;
366:1059–1062. https://doi.org/10.1016/S0140-6736(05)67402-8 PMID: 16182882
3. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic Syndrome and Risk of
Incident Cardiovascular Events and Death. J Am Coll Cardiol. 2007; 49:403–414. https://doi.org/10.
1016/j.jacc.2006.09.032 PMID: 17258085
4. Moore JX, Chaudhary N, Akinyemiju T. Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in
the United States, National Health and Nutrition Examination Survey, 1988–2012. Prev Chronic Dis.
2017; 14:160287. https://doi.org/10.5888/pcd14.160287 PMID: 28301314
5. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations.
Endocrinol Metab Clin North Am. 2004; 33:351–375. https://doi.org/10.1016/j.ecl.2004.03.005 PMID:
15158523
6. Villamor E, Finan CC, Ramirez-Zea M, Roman AV. Prevalence and sociodemographic correlates of
metabolic syndrome in school-aged children and their parents in nine Mesoamerican countries. Public
Health Nutr. 2017; 20:255–265. https://doi.org/10.1017/S1368980016002342 PMID: 27609776
7. Chan JL, Kar S, Vanky E, Morin-Papunen L, Piltonen T, Puurunen J, et al. Racial and ethnic differences
in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with
PLOS ONE Association between light exposure and metabolic syndrome
PLOS ONE | https://doi.org/10.1371/journal.pone.0238772 September 18, 2020 12 / 16
polycystic ovary syndrome: a regional cross-sectional study. Am J Obstet Gynecol. 2017; 217:189.e1–
189.e8. https://doi.org/10.1016/j.ajog.2017.04.007 PMID: 28400308
8. Gallagher EJ, LeRoith D, Karnieli E. The Metabolic Syndrome—from Insulin Resistance to Obesity and
Diabetes. Med Clin North Am. 2011; 95:855–873. https://doi.org/10.1016/j.mcna.2011.06.001 PMID:
21855696
9. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, et al. Association analyses
of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010; 42:937–
948. https://doi.org/10.1038/ng.686 PMID: 20935630
10. Turi BC, Codogno JS, Fernandes RA, Monteiro HL. Low levels of physical activity and metabolic syn-
drome: cross-sectional study in the Brazilian public health system. Cien Saude Colet. 2016; 21:1043–
1050. https://doi.org/10.1590/1413-81232015214.23042015 PMID: 27076003
11. Lian Y, Yuan Q, Wang G, Tang F. Association between sleep quality and metabolic syndrome: A sys-
tematic review and meta-analysis. Psychiatry Res. 2019; 274:66–74. https://doi.org/10.1016/j.
psychres.2019.01.096 PMID: 30780064
12. Kim CE, Shin S, Lee H-W, Lim J, Lee J, Shin A, et al. Association between sleep duration and metabolic
syndrome: a cross-sectional study. BMC Public Health. 2018; 18:720. https://doi.org/10.1186/s12889-
018-5557-8 PMID: 29895272
13. Baron KG, Reid KJ. Circadian misalignment and health. Int Rev Psychiatry. 2014; 26:139–154. https://
doi.org/10.3109/09540261.2014.911149 PMID: 24892891
14. Zimmet P, Alberti KGMM, Stern N, Bilu C, El-Osta A, Einat H, et al. The Circadian Syndrome: is the Met-
abolic Syndrome and much more! J Intern Med. 2019; 286:181–191. https://doi.org/10.1111/joim.
12924 PMID: 31081577
15. Bedrosian TA, Fonken LK, Nelson RJ. Endocrine Effects of Circadian Disruption. Annu Rev Physiol.
2016; 78:109–131. https://doi.org/10.1146/annurev-physiol-021115-105102 PMID: 26208951
16. Zephy D, Ahmad J. Type 2 diabetes mellitus: Role of melatonin and oxidative stress. Diabetes Metab
Syndr. Apr-Jun 2015; 9(2):127–31. https://doi.org/10.1016/j.dsx.2014.09.018 Epub 2014 Oct 29. PMID:
25450812
17. Saarela S, Reiter RJ. Function of melatonin in thermoregulatory processes. Life Sci. 1994; 54:295–311.
https://doi.org/10.1016/0024-3205(94)00786-1 PMID: 8289591
18. Cipolla-Neto J, Amaral FG do. Melatonin as a Hormone: New Physiological and Clinical Insights.
Endocr Rev. 2018; 39:990–1028. https://doi.org/10.1210/er.2018-00084 PMID: 30215696
19. Arendt J, Skene DJ. Melatonin as a chronobiotic. Sleep Med Rev. 2005 Feb; 9(1):25–39. https://doi.org/
10.1016/j.smrv.2004.05.002 PMID: 15649736
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